Early research (Phase 1)Active Not RecruitingNCT05485974
What this trial is testing
A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation
Who this might be right for
Lung CancerNon Small Cell Lung CancerColorectal Cancer+4 more
HUYABIO International, LLC. 44